Thursday, September 19, 2013
Publication and contact
as a viral vaccine adjuvant
Cell culture and mouse
studies suggest cGAMP could be used as an adjuvant for viral vaccines. cGAMP
synthase (cGAS) was recently identified as a
cytosolic DNA sensor that produces cGAMP, which then activates the type I
interferon pathway through the transmembrane protein 173 (STING; TMEM173) adaptor protein.
In cultured, HIV-infected, human monocytes, small hairpin RNA against cGAS or
STING decreased the production of type I interferon compared with control
shRNA. In mice infected with herpes simplex virus (HSV), knocking out cGAS
decreased immune responses and survival compared with no knockout. In mice,
immunization with cGAMP plus ovalbumin increased B and T cell
responses compared with immunization using ovalbumin alone. Next steps could
include testing formulations of HIV or HSV vaccines with cGAMP adjuvants.
Published online Sept. 19, 2013
Patent applications filed;
licensing status undisclosed
Gao, D. et al. Science;
published online Aug. 8, 2013;
Li, X.-D. et al. Science; published online Aug. 29, 2013;
Contact: Zhijian J. Chen, The University of Texas
Southwestern Medical Center, Dallas, Texas
All contents Copyright © 1993-2017 BioCentury Publications, Inc. ALL RIGHTS RESERVED. All use of this Web Site and its contents is governed by the BioCentury User Agreement
. The contents of this Web Site are protected under U.S. and foreign copyright and intellectual property laws, and no part of this Web Site or its contents may be photocopied, reproduced or retransmitted in any form without the written consent of BioCentury, which may be requested from Reprints/Permissions
. BioCentury®; The Bernstein Report on BioBusiness™; The BioCentury 100™; The Clear Route to ROI™; Because Real Intelligence is Hard to Find™; BCIQ™; and BioPharma's Knowledge Center™; are trademarks of BioCentury Publications, Inc., P.O. Box 1246, San Carlos, CA 94070. SciBX® and SciBX: Science-Business eXchange® are trademarks of Nature America, Inc. that are jointly used by BioCentury Publications, Inc. and Nature America, Inc.
Thanks for purchasing this article.
Please bookmark this url for future reference.
We have also sent you a confirming e-mail with a receipt and this same url for your
close [ X ]